Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Share
Interleukin-6, which, among its other effects, stimulates the production of red blood cells and helps control metastases, was first isolated and cloned by Prof. Michel Revel.
Application
Interleukin-6 was developed into a drug by InterPharm Laboratories Ltd. in Kiryat Weizmann, which uses it in advanced clinical trials.
Share
